U.S. Markets closed

What Drove Sarepta Therapeutics Stock in March 2018?

Margaret Patrick
What Drove Sarepta Therapeutics Stock in March 2018?

Sarepta Therapeutics (SRPT) stock has risen 19.3%, from $62.11 on March 1, 2018, to $74.09 on March 29, 2018. Its less-than-expected loss in 4Q17, mainly due to solid sales of EXONDYS 51 and nearly double the projected sales for EXONDYS 51 in fiscal 2018 compared to fiscal 2017, catapulted the stock from $62.11 on March 1, 2018, to $71.45 on March 5, 2018. On April 4, 2018, Sarepta Therapeutics was trading 263% above its 52-week low of $28.14 and 12.3% below its 52-week high of $84.37.